Deans' stroke musings: Drug made from cobra venom among pharma startup’s targeted therapeutics

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, March 31, 2012

Drug made from cobra venom among pharma startup’s targeted therapeutics

Three possibilities for use in strokes;
1. humanized cobra venom factor (CVF), a key protein in snake toxin. In studies, CVF has been found to subdue the body’s complement system, which is part of the immune system that activates cell killing.(If we can stop apoptosis we can save neurons)
2. a new class of proteasome inhibitors, which stop the degradation of proteins in cancer cell nuclei and initiate programmed cell death. Called syrbactins
(I do wonder if this is to initiate cell death or stop it)
3. a hybrid nanocarrier drug-delivery system that could target drugs directly to infected cancer cells. (nanocarriers can be very useful to get across the blood brain barrier)
http://www.medcitynews.com/2012/03/drug-made-from-cobra-venom-among-pharma-startups-targeted-therapeutics/?utm_source=rss&utm_medium=rss&utm_campaign=drug-made-from-cobra-venom-among-pharma-startups-targeted-therapeutics
An early stage pharmaceutical company with newly licensed anticancer, anti-inflammatory and nanoparticle drug-delivery technologies is looking for its first round of funding.

Pono Pharma, which was founded earlier this year with three technologies licensed from the University of Hawai’i, has already raised $1.5 million of a planned $4 million.

The rest at the link.